CSF NfH in ALS and controls.
Petra Steinacker
Lubin Fang
Jens Kuhle
Axel Petzold
Hayrettin Tumani
Albert C. Ludolph
Markus Otto
Johannes Brettschneider
10.1371/journal.pone.0023600.g003
https://plos.figshare.com/articles/figure/_CSF_NfH_in_ALS_and_controls_/416100
<p>Box and dot plots show CSF NfH<sup>SMI35</sup> in ALS, Parkinson's disease (PD), and controls (CTRL). ALS fast = patients with rapid progression of disease over follow-up of 6 months, ALS slow = patients with slow progression of disease over follow-up. The box represents the 25<sup>th</sup> to 75<sup>th</sup> quartile, the whiskers represent the range, and the horizontal line in the box represents the median. Difference between the groups was significant (p<0.001, Kruskal-Wallis Analysis of Variance on Ranks), with post-hoc analysis (Dunn's method) showing patients with ALS to have significantly higher CSF concentrations as compared to patients with PD and controls (p<0.05 each).</p>
2013-02-20 15:42:25
nfh
als